Alpha Cognition Inc. filings document the regulatory record of a British Columbia biopharmaceutical issuer with no-par-value common shares listed on Nasdaq under ACOG. The disclosures identify the company as an emerging growth company and cover formal reporting around ZUNVEYL commercialization, financial results, operational updates, and capital and compensation arrangements.
Recent Form 8-K filings address results of operations, Regulation FD disclosures, board appointments and departures, equity awards under incentive plans, and material agreements tied to legacy Memogain asset and license obligations. Proxy materials describe annual general meeting matters, including director elections, board size, auditor appointment, shareholder voting procedures, and accompanying annual financial statement materials.
Opaleye Management Inc., a ten percent owner of Alpha Cognition Inc., indirectly purchased a total of 200,086 common shares on July 22–23, 2026 for Opaleye, L.P. and a separately managed account at weighted average prices of $7.8337 and $7.7953 per share, within disclosed ranges of $7.75–$7.90 and $7.655–$7.8667. Opaleye Management may be deemed to beneficially own these securities but disclaims beneficial ownership except to the extent of its pecuniary interest.
Alpha Cognition Inc. is reported to have a significant shareholder group led by Opaleye Management Inc., Opaleye, L.P., and James Silverman, which together report beneficial ownership of 3,095,193 shares of common stock. This represents 14.22% of Alpha Cognition’s common shares, based on 21,774,104 shares outstanding as referenced in a Form 10-Q filed on May 14, 2026.
The reporting persons indicate no sole voting or dispositive power over the shares, but shared voting and shared dispositive power over 3,095,193 shares, including shares held in a managed account advised by Opaleye Management Inc. The filing notes that it should not be construed as an admission that any reporting person is the beneficial owner of the shares for purposes of Section 13 of the Exchange Act.
Opaleye Management Inc., a more than ten percent holder of Alpha Cognition Inc., reported open‑market purchases of the company’s common stock. Through Opaleye, L.P., it bought 152,336 shares on June 26, 2026 at a weighted average price of $6.4017 per share, and 197 shares on June 25, 2026 at $6.50 per share. After these trades, Opaleye, L.P. held 2,805,107 shares indirectly, while a separately managed account held 90,000 shares. The filing notes these prices reflect multiple trades between $6.335 and $6.50 and that Opaleye Management may be deemed to beneficially own these securities but disclaims beneficial ownership except to the extent of its pecuniary interest.
Alpha Cognition Inc. has an amended Schedule 13G/A showing that Opaleye Management Inc., Opaleye, L.P. and James Silverman collectively report beneficial ownership of 2,895,107 shares, representing 13.30% of the company's common stock. The filing states these shares are held directly by the fund and in a managed account over which the adviser and Mr. Silverman have shared voting and dispositive power. The percentage is calculated using 21,774,104 shares outstanding as reported in the company’s Form 10-Q filed 05/14/2026. The amendment is signed by James Silverman on behalf of the reporting persons.
Alpha Cognition Inc. reported results from its 2026 annual meeting and a board leadership change. The board appointed Dr. Robert Wills as non-executive Chair, filling the vacancy created when Len Mertz did not stand for re-election.
As of the April 24, 2026 record date, 21,774,104 common shares and 316,655 preferred shares were issued, outstanding and entitled to vote. At the meeting, 10,535,277 shares were represented in person or by proxy, establishing a quorum. Shareholders approved setting the board size at six directors, elected all six nominees, and ratified CBIZ CPAs P.C. as the company’s independent registered public accounting firm for the ensuing year.
Opaleye Management Inc., a 10% owner of Alpha Cognition Inc., reported open‑market purchases of common stock made through Opaleye, L.P. between June 11 and June 15, 2026. The fund bought 2,862 shares at $5.9053, 273 shares at $5.9321, and 4,550 shares at $5.9896 per share.
After these trades, Opaleye, L.P. held 2,652,574 Alpha Cognition shares indirectly attributed to Opaleye Management Inc., while a separately managed account held 90,000 shares. Opaleye Management Inc. may be deemed to beneficially own these securities but disclaims beneficial ownership beyond its pecuniary interest.
Opaleye Management Inc., a ten percent owner of Alpha Cognition Inc., reported indirect open-market purchases of the company’s common stock. Through Opaleye, L.P., it bought 24,856 shares on June 9, 2026 at a weighted average price of $5.9758 and 5,872 shares on June 10, 2026 at $5.9873.
Following these trades, Opaleye, L.P. held 2,644,889 Alpha Cognition shares indirectly, while a separately managed account overseen by Opaleye held 90,000 shares. The firm notes these prices reflect ranges across multiple executions and disclaims beneficial ownership beyond its pecuniary interest in the securities.
Alpha Cognition Inc. insider Opaleye Management Inc., a more than ten percent owner, reported an indirect open-market purchase of 10,054 shares of common stock on June 5, 2026 at a weighted average price of $5.8281 per share, with trades executed between $5.82 and $5.85. These shares are held by Opaleye, L.P., for which Opaleye Management serves as investment manager, bringing that fund’s holdings to 2,614,161 shares of Alpha Cognition common stock. A separately managed account associated with Opaleye Management also holds 90,000 shares. Opaleye Management states it may be deemed to beneficially own these securities but disclaims beneficial ownership except to the extent of its pecuniary interest.
Opaleye Management Inc., a 10% owner of Alpha Cognition Inc., reported a series of indirect open-market purchases of common stock. Through Opaleye, L.P., it bought a total of 73,738 shares on May 27–29, 2026 at prices around $5.73–$5.90 per share.
After these trades, indirect holdings by Opaleye, L.P. increased to 2,604,107 shares of common stock, while a separately managed account holds 90,000 shares. Opaleye Management may be deemed to beneficially own these securities to the extent of its pecuniary interest and expressly disclaims broader beneficial ownership.
Opaleye, L.P., an entity associated with Opaleye Management Inc., reported open-market purchases of Alpha Cognition Inc. common stock. On May 20, 2026, the fund bought 8,431 shares at $5.89 per share, followed by 15,945 shares at $5.70 per share on May 21, 2026.
After these trades, the fund held 2,530,369 shares indirectly, while a separately managed account associated with Opaleye held 90,000 shares. Opaleye Management Inc. disclaims beneficial ownership beyond its pecuniary interest in these positions.